Ann E Berman
CIK 1349408 · last filed 2026-03-31
Ann E Berman is a corporate insider who has filed 224 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for L, was dated Mar 31, 2026. Across all open-market trades the lifetime net is −$2.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $822.6K across reported positions. 116 SEC filings were submitted jointly with LOEWS CORP.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
LTR.WD price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
BOSTON, MA 02109
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| L | Director | 5,233 | $109.68 | $574.0K | $0 | 1 | 2026-03-31 |
| LTR.WD | Director | 4,998 | — | — | -$2.38M | 87 | 2026-02-11 |
| IMRX | Director | 67,465 | $3.69 | $248.6K | $214.3K | 9 | 2025-06-16 |
| CANTEL MEDICAL CORP (CMD) Delisted | Director | 0 | $80.37 | $0 | -$566.0K | 7 | 2021-06-02 |
| CANTEL MEDICAL CORP (CMN) Delisted | Director | 5,424 | — | — | -$692.1K | 12 | 2016-10-05 |
| LOEWS CORP (LTR) Delisted | Director | 12,900 | — | — | $489.8K | 10 | 2008-04-02 |
Recent Filings
224 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-31 | L | Grant (A) | +235 | $0 | EDGAR |
| 2026-02-11 | LTR.WD | Sell (S) | −1,922 | -$211.7K | EDGAR |
| 2026-02-10 | L | Notice (144) | −1,922 | -$211.7K | EDGAR |
| 2026-01-05 | LTR.WD | Grant (A) | +234 | $0 | EDGAR |
| 2025-12-02 | LTR.WD | Mixed | — | -$156.2K | EDGAR |
| 2025-12-01 | L | Notice (144) | −1,444 | -$156.1K | EDGAR |
| 2025-09-30 | LTR.WD | Grant (A) | +251 | $0 | EDGAR |
| 2025-09-23 | IMRX | Notice (144) | −14,000 | -$136.1K | EDGAR |
| 2025-09-03 | LTR.WD | Mixed | — | -$137.6K | EDGAR |
| 2025-09-02 | L | Notice (144) | −1,422 | -$137.5K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.